NEWS SEARCH ANALYSIS INSIGHT

360° SearchNetwork Hot Spots Trends

Advanced Search Options >>

Saturday, November 21, 2009 4:26 PM

Elan Corporation, plc

Type: Company

Name: Elan Corporation, plc (Elan Corporation Plc, Elan Corporation plc)

Nationality: Ireland

Fact Sheet: Fact Sheet for Elan Corporation, plc

First Reported 11/20/2009 - Updated 11/20/2009 - 1 Documents

Global market for anti-depressants on a decline

Alkermes, Inc. (USA)AstraZeneca Plc (UK)Boehringer Ingelheim GmbH (Germany)Bristol-Myers Squibb (USA)Cephalon, Inc. (USA)Dainippon Sumitomo Pharma Co., Ltd. (Japan)Elan Corporation Plc (Ireland)Eli Lilly and Co. (USA)Fabre-Kramer Pharmaceuticals, Inc. ... [News-Medical.Net - 11/20/2009]

Entities: United States, Belgium, Switzerland

First Reported 17 hours ago - Updated 17 hours ago - 1 Documents

Genentech Inc

Hot Topics at HBA

The 2009 Healthcare Businesswomen’s Association leadership conference is officially underway in sunny California. Last night, festivities got underway with a welcome reception for attendees followed by a “Taste of San Francisco,” which featured lively ... [Pharmaceutical Executive - 17 hours ago]

Entities: Libby Gill, Genentech Inc, Elan Corporation, plc, Shire plc

First Reported 11/16/2009 - Updated 11/16/2009 - 1 Documents

Johnson & Johnson

Johnson & Johnson Q3 2009 Earnings Call Transcript

8:30 am ET ExecutivesLouise Mehrotra - Vice President, Investor RelationsAlex Gorsky - Worldwide Chairman of our Medical Devices & Diagnostics Group Dominic Caruso - Vice President, Finance and Chief Financial OfficerAnalystsRick Wise - Leerink SwannMatt ... [Seeking Alpha - 11/16/2009]

Entities: Johnson & Johnson, Risperdal, Medical Devices

First Reported 11/10/2009 - Updated 11/11/2009 - 3 Documents

Elan Corporation PLC UK Regulatory Announcement: Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference

Elan to Present at Lazard Capital Markets 6th Annual Healthcare Conference DUBLIN, Ireland--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) today announced that it will present at the Lazard Capital Markets 6th Annual Healthcare Conference, on Tuesday, ... [Business Wire UK - 11/11/2009]

Entities: Elan Corporation, plc, Lazard Capital Markets, Health Care, Mary Stutts, Chris Burns

First Reported 10/23/2009 - Updated 10/23/2009 - 7 Documents (in Biology)

Food and Drug Administration

BRIEF-US FDA confirms 23 PML infection cases with Elan, Biogen MS drug

WASHINGTON, Oct 23 (Reuters) - U.S. Food and Drug Administration spokeswoman Sandy Walsh on Friday said:* there have been 23 confirmed cases of progressive multifocal leukoencephalopathy (PML), a potentially fatal brain infection, in patientstreated with ... [FinanzNachrichten.de - 10/23/2009]

Entities: Elan Corporation, plc, Multiple Sclerosis, Food and Drug Administration

First Reported 11/10/2009 - Updated 11/10/2009 - 2 Documents

Form 6-K ELAN CORP PLC For: Nov 10

Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++ELAN+CORP+PLC+++++++++++++For%3A+Nov+10/5095843.html for the full story. ... [Street Insider - 11/10/2009]

Entities: Elan Corporation, plc

First Reported 11/02/2009 - Updated 11/03/2009 - 2 Documents (in Internet & IT)

E.L.A.N. Ld UK Regulatory Announcement: Partial Repurchase - Replacement

LONDON--(BUSINESS WIRE)--The following amendment should be made to the 'Partial Repurchase' announcement released at 11:28am GMT yesterday November 2nd 2009.The Issuer in question should be ELAN LTD and not Elan Corp.All other details remain unchange ... [Business Wire UK - 11/03/2009]

Entities: ELAN Ltd, United Kingdom, Elan Corporation, plc

First Reported 11/11/2009 - Updated 11/11/2009 - 2 Documents (in Health)

UPDATE: Biogen, Elan, Roche Forming Brain Infection Consortium

(Adds comments from Roche in the fourth paragraph)Of DOW JONES NEWSWIRESNEW YORK -(Dow Jones)- Biogen Idec Inc. (BIIB), Elan Corp. Plc (ELN) and Roche Holding AG (RHHBY) are planning to form a research consortium dedicated to a rare brain infection that ... [Nasdaq - 11/11/2009]

Entities: Tysabri, Elan Corporation, plc, Consortium, Roche Holding Ltd

First Reported 10/29/2009 - Updated 10/30/2009 - 2 Documents (in Corporate Deals)

Elan: Expiration Of Tender Offer 7.75% Senior Notes ...

LONDON -(Dow Jones)- Elan Corporation PLC (ELN.LN), a neuroscience-based biotechnology company, said Friday that the expiration and final results of the tender offer for the 7.75% Senior Fixed Rate Notes due 2011 issued by its wholly-owned subsidiaries, ... [Morningstar UK - 10/30/2009]

Entities: Elan Corporation, plc, Tender Offer, Elan Finance Corporation Ltd, Ian Walker, Payment Date

First Reported 10/27/2009 - Updated 10/27/2009 - 2 Documents (in Health)

Subset Data from Two Randomized Phase 3 Trials Show TYSABRI

Elan Corporation, plc ELN and Biogen Idec BIIB today announced data showing that treatment with TYSABRIÂ® (natalizumab) significantly reduced the rate of hospitalization compared with placebo in patients with moderate–to–severe Crohnâs disease during ... [Business Wire via MSN Money - 10/27/2009]

Entities: Tysabri, Biogen Idec, Placebo, Crohn's disease, Elan Corporation, plc

First Reported 10/29/2009 - Updated 10/29/2009 - 2 Documents

Europe Regulators Report 4 PML Deaths On Tysabri Since '06

NEW YORK -(Dow Jones)- European regulators reported four deaths from a rare brain infection in multiple sclerosis patients taking Tysabri, sold by Biogen Idec Inc. (BIIB) and Elan Corp. PLC (ELN), since its 2006 relaunch.One other death had been reported ... [Nasdaq - 10/29/2009]

Entities: Tysabri, Elan Corporation, plc, Multiple Sclerosis

First Reported 10/30/2009 - Updated 10/30/2009 - 2 Documents (in Corporate Deals)

BRIEF-Elan Corp result of tender offer for note due 2011

LONDON, Oct 30 (Reuters) - Elan Corp PLC:* Announced the expiration and final results of the tender offer for the 7Â¾%notes due 2011* The co-issuers had received tenders in respect of $783.9 million aggregateprincipal amount of notes* Between the Early ... [Forbes.com - 10/30/2009]

Entities: Tender Offer, Elan Corporation, plc, London

Quotes

...they failed to get U S patents for many peptides they isolated and identified during the course of their 15-year research project on Conus snails. "Olivera tried to write the company (Elan Pharmaceuticals), saying, 'You know, you should at least give [us something]. They didn't want to,' Cruz said. She explained that at the time, Philippine scientists 'frowned upon' the use scientific discoveries for economic gain and the country did not have a working patenting system in the 1970s."

Filipina scientist wins P4.6-M prize for snail toxin work [ABS-CBN News - 11/13/2009]

...changes are difficult under any circumstances, and will have a very personal impact on people who have been dedicated to the mission of ," he said. "We recognize their contributions to the achievements of our business, and are committed to treating them fairly and with respect throughout this process." Nevertheless, J&J has been on a buying spree for most of 2009...

J&J may cut more than 8,000 jobs [Drug Discovery News - 11/03/2009]

Elan Corporation plc ELN ( "Elan') today announced the expiration and final results of the tender offer for the 7Â¾% Senior Fixed Rate Notes due 2011 (CUSIP No. 284138AC8) (the âNotesâ) issued by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. (the âCo-Issuersâ). The tender offer expired on October 28, 2009, at 11:59 p.m., New York City time (the 'Expiration Date'). On October 14, 2009, the Co-Issuers made a payment in cash for all Notes tendered prior to 11:59 p.m., New York City time, on October 13, 2009 (the 'Early Tender Date'). As of the Early Tender Date, the Co-Issuers had received tenders in respect of $783.9 million aggregate principal amount of Notes, representing approximately 92.23% of the outstanding Notes, all of which were accepted for purchase. The holders of such Notes received total consideration of $1,019.38 per $1,000 of principal amount tendered. The total consideration included an early tender premium of $30.00 per $1,000 principal amount of Notes tendered. The total cash payment to purchase such Notes, including accrued and unpaid interest up to, but not including, the early payment date, was approximately $824.3 million."

Elan Corporation Plc Announces Expiration of Tender Offer for 7Â¾% [Business Wire via MSN Money - 10/29/2009]

More Content

sort by: Date \| Relevance
Hot Topics at HBA [Pharmaceutical Executive - 17 hours ago]
HealthCor Urges Biogen Board Consider Number Of... [Nasdaq - 22 hours ago]
Global market for anti-depressants on a decline [News-Medical.Net - 11/20/2009]
Research and Markets: Central Nervous System Th... [Business Wire - 11/19/2009]
Research and Markets: Central Nervous System Th... [Business Wire UK - 11/19/2009]
Merrion Pharmaceuticals Announces Interim Manag... [Pharmacy Choice - 11/17/2009]
Johnson & Johnson Q3 2009 Earnings Call Tra... [Seeking Alpha - 11/16/2009]
Merrion Pharmaceuticals Opens New Custom-Built ... [Pharmacy Choice - 11/16/2009]
New Higher Dose of Focalin XR Improves Control ... [Pharmacy Choice - 11/16/2009]
Merrion Pharmaceuticals Selected To Present At ... [Pharmacy Choice - 11/14/2009]
Filipina scientist wins P4.6-M prize for snail ... [ABS-CBN News - 11/13/2009]
Elan to Present at Lazard Capital Markets Annua... [Individual.com - 11/13/2009]
XOM, ELN, X, WY, FO and GCA Free Research repor... [Yahoo! Canada - 11/12/2009]
News and FDA Updates for Alexion (Nasdaq:ALXN),... [American Chronicle - 11/12/2009]
UPDATE: Biogen, Elan, Roche Forming Brain Infec... [Nasdaq - 11/11/2009]
Biogen, Elan, Roche Form Consortium To Study Br... [Nasdaq - 11/11/2009]
Elan Corporation PLC UK Regulatory Announcement... [Business Wire UK - 11/11/2009]
Form 6-K ELAN CORP PLC For:... [Street Insider - 11/10/2009]
Form 6-K ELAN CORP PLC For:... [Street Insider - 11/10/2009]
Elan to Present at Lazard Capital Markets 6th A... [Business Wire via MSN Money - 11/10/2009]
Elan to Present at Lazard Capital Markets 6th A... [Stockwatch - 11/10/2009]
Biogen Updates Tysabri Label To Reflect Risk Wi... [Nasdaq - 11/06/2009]
Written Requests Issued [FDA - 11/06/2009]
J&J to cut 7000 jobs [The Money Times - 11/05/2009]
J&J chief calls job cuts 'difficult' [TheDeal.com - 11/03/2009]
J&J to cut 6-7 percent of workforce in rest... [Exec Digital US - 11/03/2009]
J&J slashing workforce [Reuters UK - 11/03/2009]
J&J slashesÂ Â Â Â ... [MarketWatch - 11/03/2009]
J&J may cut more than 8,000 jobs [Drug Discovery News - 11/03/2009]
Johnson & Johnson to axe 8,190 global jobs [Times Online - 11/03/2009]

Blogs

sort by: Date \| Relevance
UPDATE 2-HealthCor slams Biogen CEO for outsize... [Economy-Finance - 19 hours ago] * HealthCor criticizes Biogen CEO paycheck, stock sales * Calls on company to initiate sustained buyback program * Says company should cut R&D expenses (Updates ...
Top 10 Analyst Upgrades, Downgrades, Initiation... [24/7 Wall St. - 10/29/2009] These are this Thursday morning’s top 10 analyst upgrades, downgrades, and initiations we have seen in early research calls from Wall Street: ArcelorMittal (NYSE: ...
J&J lowers price of Elan stake [The Deal.com - 09/15/2009] Irish drugmaker Elan Corp. plc has revised its agreement with healthcare giant Johnson & Johnson and will get $885 million for an 18.4% stake in the company -- $115 ...
J&J and Elan Cut Deal Price to Resolve Biog... [DealBook - 09/15/2009] Johnson & Johnson has cut the amount it will pay for its 18.4 percent stake in Irish drugmaker Elan Corp by $115 million to $885 million, Elan confirmed Monday. ...
The Morning’s News: Word Up! Microsoft Wins a S... [WSJ.com: Law Blog - 09/04/2009] A few items we’ve got to get to, LBers, this morning, just to make sure you’re well-informed before you put your head down and churn out a few last billables before ...

Change Password

Log in to Silobreaker

Advanced Search Options

Elan Corporation, plc